CHIERON ACTIVE INGREDIENTS PRIVATE LTD

Overview

CHIERON ACTIVE INGREDIENTS PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 22 active FDA Type II Drug Master Files, covering 1-CHLORO-6,6-DIMETHYLHEPT-2-EN-4-YNE; DAPAGLIFLOZIN PROPANEDIOL; ESCITALOPRAM OXALATE USP; FLUCONAZOLE USP; IRBESARTAN USP; LACOSAMIDE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances CHIERON ACTIVE INGREDIENTS PRIVATE LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

CHIERON ACTIVE INGREDIENTS PRIVATE LTD holds 16 active (16 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• OSELTAMIVIR PHOSPHATEActive2026-04-14
• DAPAGLIFLOZIN PROPANEDIOLActive2025-11-27
• RITALINIC ACIDActive2025-10-23
• RIVAROXABAN USPActive2025-07-01
• SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2025-06-12
• WARFARIN SODIUM CLATHRATEActive2021-10-14
• TETRACAINE HYDROCHLORIDEActive2021-06-22
• VILDAGLIPTINActive2021-05-21
• RISPERIDONEActive2021-03-26
• LINAGLIPTINActive2021-03-20
• LEVETIRACETAMActive2020-10-27
• OLMESARTAN MEDOXOMIL-ROUTE AActive2019-10-08
• LACOSAMIDEActive2019-02-04
• TETRACAINE USPActive2010-08-26
• OLMESARTAN MEDOXOMILActive2009-09-30

Showing 15 of 16 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHIERON ACTIVE INGREDIENTS PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.